Healthcare entity

Nandini Piramal

Person

Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention AbbVie Therapeutics India Private Limited, the most common co-covered peer. The average consequence score is 6, matching the 6 beat baseline for this window.

Last mentioned: Jul 27, 2026

RSS updates
Share

Entity pulse

Recent coverage · Nandini Piramal

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Nandini Piramal

Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention AbbVie Therapeutics India Private Limited, the most common co-covered peer. The average consequence score is 6, matching the 6 beat baseline for this window. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. Nandini Piramal appears in 1 tracked Healthcare story from July 27, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Nandini Piramal. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Nandini Piramal 1

Nandini Piramal is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.